Combination therapy with olaparib and abiraterone acetate for metastatic castration-resistant prostate cancer.

Lancet Oncol

Department of Urology, La Croix du Sud Hospital, Toulouse, France; Department of Urology, Institut Universitaire du Cancer Toulouse-Oncopôle, Toulouse, France.

Published: October 2023

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(23)00448-5DOI Listing

Publication Analysis

Top Keywords

combination therapy
4
therapy olaparib
4
olaparib abiraterone
4
abiraterone acetate
4
acetate metastatic
4
metastatic castration-resistant
4
castration-resistant prostate
4
prostate cancer
4
combination
1
olaparib
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!